Paul Christian Lauterbur (May 6, 1929 – March 27, 2007) was an American chemist who shared the Nobel Prize in Physiology or Medicine in 2003 with Peter Mansfield for his work which made the development of magnetic resonance imaging (MRI) possible.
Lauterbur was a professor at Stony Brook University from 1963 until 1985, where he conducted his research for the development of the MRI. In 1985 he became a professor along with his wife Joan Dawson at the University of Illinois at Urbana-Champaign for 22 years until his death in Urbana. He and Dawson established the Biomedical Magnetic Resonance Laboratory (BMRL) there. He never stopped working with undergraduates on research, and he served as a professor of chemistry, with appointments in bioengineering, biophysics, the College of Medicine at Urbana-Champaign and computational biology at the Center for Advanced Study.
When he was drafted into the United States Army in the 1950s, his superiors allowed him to spend his time working on an early nuclear magnetic resonance (NMR) machine; he had published four scientific papers by the time he left the Army. Paul became an atheist later on.Dawson, M. Joan. Paul Lauterbur and the Invention of MRI. Cambridge, MA: MIT, 2013. Print. "Paul became an atheist, revering intellectual honesty and the quest for truth."
The Nobel Prize in Physics in 1952, which went to Felix Bloch and Edward Purcell, was for the development of nuclear magnetic resonance (NMR), the scientific principle behind MRI. However, for decades magnetic resonance was used mainly for studying the chemical structure of substances. It wasn't until the 1970s with Lauterbur's and Mansfield's developments that NMR could be used to produce images of the body.
Lauterbur used the idea of Robert Gabillard (developed in his doctoral thesis, 1952) of introducing gradients in the magnetic field which allows for determining the origin of the emitted from the atomic nucleus of the object of study. This spatial information allows two-dimensional pictures to be produced.
Raymond Damadian's 1971 Science paper on his observation of T1 and T2 differences in cancerous tissueDamadian, R. V. "Tumor Detection by Nuclear Magnetic Resonance", Science 171(3976):1151–1153, March 19, 1971 | doi:10.1126/science.171.3976.1151. was influential, as Lauterbur wrote in 1986, "… the attention of the medical community was first attracted by the report of Damadian that some animal tumors have remarkably long water proton relaxation times... I wondered whether there might be some way to noninvasively map out such quantities within the body."Lauterbur, P. C. "Cancer detection by Nuclear Magnetic Resonance Zeugmatographic Imaging", Cancer 57:1899–1904, May 15, 1986 | doi:10.1002/1097-0142(19860515)57:10<1899::AID-CNCR2820571002>3.0.CO;2-4. Prompted by Damadian's report on the potential medical uses of NMR, Lautebur expanded on Herman Carr's technique Physics Today July 2004 – Field Gradients in Early MRI on creating a one-dimensional magnetic resonance (MR) image to develop a way to generate the first MRI images, in 2D and 3D, using gradients.
While Lauterbur conducted his work at Stony Brook, the best NMR machine on campus belonged to the chemistry department; he had to visit it at night to use it for experimentation and would carefully change the settings so that they would return to those of the chemists' as he left. The original MRI machine is located at the Chemistry building on the campus of Stony Brook University in Stony Brook, New York.
Some of the first images taken by Lauterbur included those of a 4-mm-diameter clam his daughter had collected on the beach at the Long Island Sound, green peppers and two test tubes of heavy water within a beaker of ordinary water; no other imaging technique in existence at that time could distinguish between two different kinds of water. This last achievement is particularly important as the human body consists mostly of water.
When Lauterbur first submitted his paper with his discoveries to Nature, the paper was rejected by the editors of the journal. Lauterbur persisted and requested them to review it again, upon which time it was published and is now acknowledged as a classic Nature paper. The Nature editors pointed out that the pictures accompanying the paper were too fuzzy, although they were the first images to show the difference between heavy water and ordinary water. Lauterbur said of the initial rejection: "You could write the entire history of science in the last 50 years in terms of papers rejected by Science or Nature."
Peter Mansfield of the University of Nottingham in the United Kingdom took Lauterbur's initial work another step further, replacing the slow (and prone to artefacts) projection-reconstruction method used by Lautebur's original technique with a method that used frequency and phase encoding by spatial gradients of magnetic field. Owing to Larmor precession, a mathematical technique called a Fourier transformation could then be used to recover the desired image, greatly speeding up the imaging process.
Lauterbur unsuccessfully attempted to file patents related to his work to commercialize the discovery. The State University of New York chose not to pursue patents, with the rationale that the expense would not pay off in the end. "The company that was in charge of such applications decided that it would not repay the expense of getting a patent. That turned out not to be a spectacularly good decision," Lauterbur said in 2003. He attempted to get the federal government to pay for an early prototype of the MRI machine for years in the 1970s, and the process took a decade. The University of Nottingham did file patents which later made Mansfield wealthy.
The New York Times published an editorial saying that while scientists credit Damadian for holding an early patent in MRI technology, Lauterbur and Mansfield expanded upon Herman Carr's technique in order to produce first 2D and then 3D MR images. The editorial deems this to be worthy of a Nobel prize even though it states clearly in Alfred Nobel's will that prizes are not to be given out solely on the basis of improving an existing technology for commercial use. The newspaper then points out a few cases in which precursor discoveries had been awarded with a Nobel, along with a few deserving cases in which it had not, such as Rosalind Franklin, Oswald Avery, .
|
|